United States Patent and Trademark Office March 2022 – Federal Register Recent Federal Regulation Documents
Results 1 - 1 of 1
Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; COVID-19 Vaccine Supplemental Medical Provider Statement
The United States Patent and Trademark Office (USPTO), as required by the Paperwork Reduction Act of 1995, invites comments on the extension and revision of an existing information collection: 0651- 0087 (COVID-19 Vaccine Supplemental Medical Provider Statement). The purpose of this notice is to allow 60 days for public comment preceding submission of the information collection to OMB.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
